Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering
Krentz NAJ, Shea LD, Huising MO, et al.
Lancet Diabetes Endocrinol. 2021;9(10):708-724
Leggi
Breaking news
A clinical conundrum: intensifying glycemic control in the presence of advanced diabetic retinopathy
Ipp E, Kumar M
Diabetes Care. 2021;dci210029.
Leggi
Cardiovascular outcomes in patients with type 2 diabetes and obesity: comparison of gastric bypass, sleeve gastrectomy, and usual care
Aminian A, Wilson R, Zajichek A, et al.
Diabetes Care. 2021; dc203023
Leggi
Insulin therapy development beyond 100 years
Home PD, Mehta R
Lancet Diabetes Endocrinol. 2021;9(10):695-707
Leggi
Effect of maternal metformin treatment in pregnancy on neonatal metabolism: evidence from newborn metabolic screening
Estrella J, Wiley V, Simmons D, et al.
Diabetes Care. 2021;dc210327
Leggi
Updated USPSTF screening recommendations for diabetes. Identification of abnormal glucose metabolism in younger adults
Grant RW, Gopalan A, Jaffe MG
JAMA Intern Med. 24 Aug 2021
Leggi
New USPSTF recommendations for screening for prediabetes and type 2 diabetes an opportunity to create national momentum
Gregg EW, Moin T
JAMA. 2021;326(8):701-703
Leggi
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Sattar N, Lee MMY, Kristensen SL, et al.
The Lancet Diabetes & Endocrinology. Pub online 20 August 2021
Leggi
Screening for prediabetes and type 2 diabetes. US preventive services task force recommendation statement
Davidson KW, Barry MJ, Mangione CM, et al.
JAMA. 2021;326(8):736-743
Leggi
Empagliflozin in heart failure with a preserved ejection fraction
Anker SD, Butler J, Filippatos G, et al.
N Engl J Med. 27 August 2021
Leggi